Global Companion Animal Health Market - Growth, Trends and Forecasts (2017 - 2022)
|発行||Mordor Intelligence LLP||商品コード||319394|
|出版日||ページ情報||英文 190 Pages
|世界のコンパニオンアニマル医療市場 Global Companion Animal Health Market - Growth, Trends and Forecasts (2017 - 2022)|
|出版日: 2017年01月24日||ページ情報: 英文 190 Pages||
The global market for companion animal healthcare is valued at $9.16 billion in 2013. Expected to grow at a CAGR of 7.86%, the market is set to reach $13.37 billion by 2020.
The companion animal health market is segmented based on type of products i. e Vaccines, Paraciticides, Anti-infectives, Medicinal feed additives, and other pharmaceuticals, based on diagnostics i.e Enzyme Linked Immuno sorbent assay(ELISA), Rapid Immuno Migration( RIM), based on genetics,based on geography market is divided into North America, Asia-Pacific, Europe and Rest of World. Europe accounts for the largest share of the animal vaccines market, followed by North America. The developing regions like Asia-pacific and Africa are expected to form a new revenue pocket in the market. Countries such as India, China, Brazil will be the major contributors in the market.
Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global companion animal health market
What makes our report unique?
1) In depth analysis of current market trends and future forecasts of the market based on different products available for both companion animals and farm animals
2) We provide longest possible market segmentation of the market based on products available, diagnostics, genetics , and geography. We give you the competitive landscape for the market which provides information about major players in the market, Market Share and recent developments.
3) High level analysis on products i.e Vaccines, anti-infectants, MFA, Paraciticides andintroduced novel vaccines such as DNA and recombinant vaccines.